Reclassification of preamendments devices
This article was originally published in The Gray Sheet
Executive Summary
Final rule issued March 31 withholds action on 10 of the 38 preamendments devices previously proposed for reclassification from Class III to Class II, including pacemaker lead adapters, annuloplasty rings and vascular graft prostheses less than 6 mm in diameter (1"The Gray Sheet" March 22, 1999, p. 10). The agency announced the postponement of action for six of the devices in June due to the lack of existing guidance to serve as special controls. Rule finalizes downclassification of remaining 28 devices, all of which are addressed by FDA guidance
You may also be interested in...
FDA Issues First Mass Downclassification Of Preamendments Class III Devices
FDA's reclassification of 38 preamendments devices from Class III into Class II cuts to less than 30 the number of pre-1976 Class III devices on which the Center for Devices and Radiological Health has not initiated some regulatory action.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.